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Abstract
Th17 cells together with their hallmark cytokine interleukin (IL)-17 were identified as crucial contributing factors in the pathogenesis of
thyroid autoimmunity. The cytokine-regulated tight junction (Tj) disruption is thought to be essential in the initiation and/or
development of several diseases. Still, the role of IL-17 maintaining Tj integrity in autoimmune thyroid diseases (AITDs) has not yet
been evaluated.We aimed to investigate integrity of the thyroid follicle by studying immunoexpression of cellular Tj – zonula occludens
(ZO)-1 and claudin-1 proteins coupled to IL-17A and CD68 detection in AITD patients compared with controls.
Thirty-five adult patients undergoing thyroidectomy and presenting 18 cases of Hashimoto thyroiditis (HT), 7 of Graves’ disease
(GD) as well as 10 subjects of colloid goiter without autoimmune component served as controls were enrolled in this study. An
immunohistochemical analysis including IL-17A, ZO-1, claudin-1, and CD68 detection was performed in each case. The correlation
of IL-17A with Tj and CD68 in patients with AITD was also analyzed.
Apart from inflammatory cells, we evidenced a stronger expression level of IL17A in the thyroid follicular cells in HT patients when
compared with GD or colloid goiter. A significant reduction of ZO-1 immunoreactivity was observed in the thyrocytes in HT patients,
whereas no significant differences were found in claudin-1 expression in HT and GD compared with colloid goiter patients. A
significantly higher number of thyroid follicles with CD68-positive cells was found in HT patients than that in patients with GD or colloid
goiter. In HT patients, the expression of IL-17A in the follicular cells was positively correlated with CD68 immunopositivity, whereas no
association with claudin-1 or ZO-1 expression was found. GD patients did not reveal any significant correlation of IL-17A with Tj and
CD68.
Strong overexpression of IL-17A observed in the thyroid epithelial cells is associated with the presence of intrafollicular CD68-
positive cells in HT patients. We evidenced the changes in molecules of thyrocyte junctional complexes highlighting impairment of the
thyroid follicle integrity in HT, but no association with IL-17A was found.
Abbreviations: AITD= autoimmune thyroid diseases, GD=Graves’ disease, HT=Hashimoto thyroiditis, IL= interleukin, T helper
= Th, Tj = tight junctions, TPO = thyroid peroxidase, TSHR = thyroid-stimulating hormone receptor, ZO = zonula occludens.
Keywords: Graves’ disease, Hashimoto thyroiditis, interleukin-17, tight junction protein
1. Introduction
The prevalence and incidence of autoimmune diseases including
autoimmune thyroid diseases (AITD) has increased significantly
over the last decades.[1] Thyroid autoimmunity occurs as a result
of immune system impairment leading to the breakdown of self-
tolerance to the 3 major thyroid proteins and inflammatory cell,
predominantly lymphocytic infiltration of the gland.[2] It is
critical to identify immunological and pathomorphological
aspects involved in thyroid autoimmunity. AITD comprise 2
clinically and pathogenetically diverse phenotypes: Hashimoto
thyroiditis (HT) and Graves’ disease (GD). GD induced by
thyroid-stimulating autoantibodies to thyroid stimulating hor-
mone receptor leading to hyperthyroidism is considered to be a T
helper type (Th)2-related disease, whereas in HT Th1-driven
autoimmune response characterized by the lymphocytic infiltra-
tion results in apoptosis of thyrocytes and subsequent hypothy-
roidism.[3,4] However, an evident humoral autoimmune response
in HT patients and diversity of T cell mediated response and
inflammatory infiltration in GD is also demonstrated.[4,5]
Recently, Th17 cells and their hallmark cytokine (interleukin,
IL)-17 have been recognized as crucial contributors to the
pathogenesis of thyroid autoimmunity.[6–8] Production of IL-
17A and IL-17F is characteristically attributed toTh17 cells. These
ILs can act on a broad range of cells, including epithelial cells,
fibroblasts, and macrophages inducing the release of proinflam-
matory tissue mediators such as interleukins IL-1b, IL-6, and IL-8,
growth and hematopoiesis stimulating factors – tumor necrosis
factor-a (TNF-a), granulocyte-macrophage colony-stimulating
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factor, and granulocyte colony-stimulating factor (G-CSF), and
tissue components degrading enzymes metalloproteinases.[9–12]
Early studies demonstrated that IL-17 stimulates production of
other cytokines such as IL-6, IL-8, and G-CSF in nonimmune cells
such as connective tissue fibroblasts and epithelial cells via
activation of the nuclear factor-kB (NF-kB) transcription fac-
tor.[13,14] In addition, IL-17 demonstrates strong synergic action
being combined with other cytokines, such as IL-1b and
TNFa.[15,16] Previous studies have shown that patients suffering
fromAITDhave enhanced levels of IL-17A andTh17 lymphocytes
revealed in blood and colonizing thyroid tissue aswell as amarked
in vitro differentiation of Th17 cells; however, the expression level
of IL-17A in the thyroid epithelial cells assessed by immunohis-
tochemistry has not been addressed thoroughly before.
Tight junctions (Tj), also called occluding junctions, are
composed of a complex, interwoven network of membrane
proteins and glycoproteins. These are distinguished at the apical
part of the lateral membranous surface of polarized endothelial
and epithelial cells. Tj maintain cell polarity and establish the
barrier sealing the paracellular space between neighboring
thyrocytes. Numerous studies have demonstrated that claudin
family is the key component of Tj, fully performing paracellular
barrier function in the absence of occludin.[17] From the currently
known 27 claudins expressed in humans, claudin-1 is considered
to be the most important member responsible for the epithelial
barrier integrity.[18] Furthermore, claudin-1 deficiency appeared
to cause vital alterations of barrier function leading to the death
of claudin-1 deficient mice.[19] Simultaneously, an essential role
of interactions of zonula occludens (ZO)-1 protein and claudin
for formation of Tj assembly have been recognized. Numerous
studies with ZO-1 and/or ZO-2 knockdown cells demonstrated
disruption in both claudin localization and paracellular perme-
ability. Moreover, in the absence of ZO-1, these cells have been
shown to exhibit polarity but fail to form Tj.[20]
Continuing studies have highlighted a broad spectrum of
cytokines able to affect the crucial function – barrier function of
endothelial and epithelial cells by influencing the structural and
functional characteristics of the Tj. Many ILs were found to
modulate Tj proteins such ZO-1, occludin, and claudin proteins
causing downregulation of these molecules[21,22]; however, the
role of IL-17 in the maintenance of Tj integrity in AITD patients
has not yet been evaluated. This study investigates integrity of the
thyroid follicle by studying immunoexpression of cellular Tj –
ZO-1 and claudin-1 proteins coupled to IL-17A and CD68
detection in AITD patients compared with controls. The
correlation of IL-17A with Tj and CD68 in patients with AITD
was also assessed, thus making an attempt to determine the
possible relationship between IL-17 and Tj integrity.
2. Methods
2.1. Patients
Twenty-five adult AITDpatients presenting 18 cases ofHT and 7 of
GDwere enrolled in this study.Tenageandgender-matched cases of
colloid goiter without autoimmune component, which served as a
control group, were also recruited. The mean age of AITD patients
and controls was 49.68±11.01 years (range, 28–68 years; 23
females) and 47.90±11.29 years (range, 33–71 years; 9 females),
respectively. AITDwere confirmed by the clinical diagnostic criteria
of HT and GD, complemented by results of thyroid biochemistry,
ultrasound imaging, and histopathology findings. Patients with GD
had thyroid hormone levels above the reference range, positive anti-
thyroid stimulating hormone receptor (anti-TSHR) antibodies, and
diffuse goiter proved by ultrasound examination. Anti-TSHR
antibodies were negative, whereas antibodies to thyroid peroxidase
(anti-TPO) and/or thyroglobulin were found at high titers in all HT
patients, and thyroid ultrasound examination showed signs of
chronic autoimmune thyroiditis. Ten patients with colloid goiter
were used as a control group.Theywere euthyroid anddisplayed the
absence of thyroid antibodies. The current study was approved by
the Riga Stradins University Ethics Committee, and all patients gave
informed consent.
Thyroid tissue blocks of 35 thyroidectomy samples (equal to
the number of patients enrolled in the study) along with the
histopathology reports were obtained from Pathology Center of
Riga East Clinical University Hospital, Latvia, between January
2013 and December 2014. All available specimens were
analyzed, and a single representative paraffin-embedded block
was chosen for immunohistochemical study.
2.2. Immunohistochemistry
Thyroid tissues were formalin-fixed and embedded in paraffin
blocks; thereafter, 4 to 5 mm thick sections were cut from blocks,
collected and fixed on slides. The diagnosis was confirmed
analyzing the slides stained routinely with hematoxylin and
eosin. Immunohistochemical reactions were performed manually
on deparaffinized thyroid tissue sections using the following
primary antibodies: polyclonal rabbit anti-IL-17A (Biorbyt,
Cambridge, UK, dilution 1:300); polyclonal rabbit anti-ZO-1
(Biorbyt, Cambridge, UK, dilution 1:200), and polyclonal rabbit
anti-claudin-1 (Biorbyt, Cambridge, UK, dilution 1:100) anti-
bodies. In addition, macrophages were visualized by monoclonal
mouse anti-CD68 antibody (DacoCytomation, Glostrup,
Denmark, clone PG-M1, dilution 1:100), which recognizes
and labels lysosomal membranes and shuttle vesicles travelling
between lysosomes and the plasma membrane of these cells. PG-
M1 reacts strongly with a fixative-resistant epitope of macro-
phage-restricted intracytoplasmic molecule.
The results of immunohistochemical reactions were visualized
by use of highly sensitive HRP Polymer system –HiDef Detection
system manufactured by CellMarque, Rocklin, CA. The antigen
sites were visualized applying 3,3’-diaminobenzidine tetrahydro-
chloride [DAB+Chromogen and DAB+Substrate buffer (Cell-
Marque, Rocklin, CA)], whereas nuclei were stained with Mayer
hematoxylin. Finally, the stained sections were mounted in Roti–
Histokitt (Carl Roth, Karlsruhe, Germany). Negative immuno-
histochemical controls were performed either by omitting of the
primary antibody or substitution of it with buffer solution. Two
certified pathologists with no access to the clinical records and
histopathological data contributed to the verification of the
immunohistochemistry results. Tissue sections were analyzed
applying both low and high power magnification from100 up
to400. Microphotographs were taken with a Leitz DMRB
microscope (Leica, Wetzlar, Germany) equipped with a digital
camera Leica DFC 450C.
Immunofluorescence staining of IL-17A was performed using
goat anti-mouse IgG-FITC: sc-2010 (Santa Cruz Biotechnology,
Inc., Santa Cruz, CA, dilution 1:300); sections were counter-
stained with 4’,6-diamidino-2-phenylindole (DAPI) (Thermo
Fisher Scientific, Invitrogen, UK, dilution 1:3000) and finally
embedded in Prolong Gold with DAPI (Thermo Fisher Scientific,
Invitrogen, UK). Digital images were captured using confocal
microscope Eclipse Ti-E (Nikon).
Cells were considered immunopositive when labeled by the
aforementioned antibodies revealed brown reaction products. IL-
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17, claudin-1, and ZO-1 positive structures displayed either
cytoplasmic or membranous reaction pattern.
Levels of immunopositivity for IL-17A and claudin-1 were
assessed semiquantitatively distinguishing the following grades:
negative (0), weak (1), moderate (2), or strong (3), when cells
were positive at 0% to 5%, 6% to 25%, 26% to 50%, or>50%,
respectively, whereas, for ZO-1 – negative (0), very weak or
discontinuous (1), weak (2), and strong or intact (3) following the
recommendations of Abd El Atti and Shash.[23]
CD68 positivity was defined as the percentage of CD68-
positive thyroid follicles determined by counting total number of
thyroid follicles with CD68-positive cells in 15 representative
fields at high magnification (400).
2.3. Statistical analysis
Immunohistochemical results were expressed as medians and
interquartile range. Mann– Whitney test was applied to examine
differences between 2 groups and Kruskal–Wallis H test – for more
than 2 study groups. To assess the potential correlations between
estimated variables, Spearman rank correlation test was carried out.
A2-tailed significance level of .05was applied. Statistical testingwas
performed using SPSS (version 20.0, IBM, Armonk, NY).
3. Results
Microscopic examination of slides processed for routine
histopathology revealed widespread mild-to-extensive inflamma-
tory infiltration of the thyroid gland by lymphocytes, macro-
phages, and plasma cells in AITD. Intraepithelial lymphocytes
were also seen. HT patients demonstrated extensive diffuse
inflammatory infiltration (7; 39%), lymphoid follicles formation
(6; 33%), or rarely mild inflammation of the thyroid gland
without lymphoid follicle formation (5; 28%). Some HT patients
revealed a marked stromal fibrosis qualified as interfollicular
presented with the deposition of increasingly accumulated
collagenous fibers and lymphoplasmacytic infiltration in the
interfollicular area, thus separating and distorting the thyroid
follicles. Still, some tissue blocks obtained from HT patients
revealed extensive destruction of thyroid parenchyma with
minimal residual follicles. Simultaneously, the vast majority of
GD patients presented with mild inflammatory cell infiltration
and diffuse hyperplasia of the follicular cells.
The results describing immunohistochemical expression of the
antigens tested in the given study and applied to the study groups
are summarized in Table 1. In HT patients, the expression of IL-
17A was detected both in the inflammatory lymphocytic
infiltrates and follicular epithelial cells confirmed by immunohis-
tochemistry and immunofluorescence (Fig. 1A). Notably, thyroid
epithelial cells located close to lymphocytes or surrounded by
inflammatory cells had a strongly marked IL-17A immunopo-
sitivity. Moreover, these thyroid follicles revealed atrophic
changes with destruction of epithelial cells and nuclear
polymorphism (Fig. 1B). By contrast, the tissues obtained from
ordinary colloid goiter and GD patients demonstrated mostly the
weak or almost negative expression of IL-17A. Only in 1 case of
GD and 1 case of colloid goiter the grade of IL-17A positivity was
≥3 and≥2, respectively. The highest expression level of IL-17A in
the follicular epithelial cells was observed in HT patients: 11 out
of 18 cases demonstrated IL-17A staining grade of 2 to 3.
Furthermore, in HT and GD patients, it was significantly higher
than colloid goiter (P< .001; P= .007, respectively) (Fig. 2A).
When studying the occurrence and localization of Tj proteins,
and more specifically claudin-1 by the use of immunohistochem-
istry, we found that it displayed a circumferential and
Table 1
Immunohistochemical expression patterns of tested antigens in









Hashimoto thyroiditis 2.4 (1.8–2.8) 0.5 (0.5–1) 1.5 (1–2.2) 23.5 (8.9–38.3)
Graves’ disease 1.4 (1–2.4) 2 (1.5–2) 1.2 (1–1.4) 10.8 (5.4–13.2)
Colloid goiter 0.8 (0.6–1) 2 (1.5–2.5) 1.6 (1.2–2.0) 5.6 (3.1–8.7)
IL= interleukin, IQR= interquartile range, ZO= zonula occludens.
Figure 1. Immunohistochemistry. (A) IL-17A positivity demonstrated in the
remnants of thyroid follicles and lymphoid follicles as well as in some
inflammatory cells in HT patient (x200). Confocal microscopy, representative
images of IL-17A positive thyrocytes, and lymphocytes: green staining shows
IL-17A specific staining, blue staining shows nuclei, inserts (x1000). (B)
Destructive IL-17A positive thyroid follicles surrounded by inflammatory cells in
HT patient (x400). (C) Moderate circumferential membranous claudin-1
immunostaining revealed in GD patient (400). (D) Strong membranous
claudin-1 expression in the thyroid follicular cells in HT patient (250). (E) Weak
ZO-1 immunoreactivity in GD patient (x250). (F) Colloid goiter evidencing weak
to moderate and moderate positive ZO-1 expression in the thyrocytes and
vascular endothelium, respectively (x250). (G) Cluster of CD68-positive cells
demonstrated within the thyroid follicle in HT patient (x400). (H) Occasional
intrafollicular CD68-positive cells individually distributed within the lumen of
thyroid follicles in HT patient (x250). GD=Graves’ disease, HT=Hashimoto
thyroiditis, IL= interleukin, ZO=zonula occludens.
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membranous pattern related to the thyroid epithelial cells
(Fig. 1C, D). The expression of claudin-1 was greatly varying
from being almost nil in one-third of HT cases (6; 33%), but still
being heavily expressed in others (5; 28%). There were no
significant differences found in claudin-1 expression levels
between patients with AITD and colloid goiter (Fig. 2B).
However, the number of claudin-1 positive follicles in HT
patients was significantly higher than that demonstrated in
colloid goiter (P= .03 and data not shown).
Regarding the second Tj protein – ZO-1 in the thyroid tissue
samples studied, HT patients demonstrated predominantly
negative and very weak or discontinuous ZO-1 expression
patterns. In 10 HT cases (56%), ZO-1 staining score was 0 to 1,
whereas only 1 specimen (14%) showed such staining score in
GD group. Immunohistochemical analysis revealed a significant
reduction of ZO-1 expression level in the follicular epithelial cells
in HT patients when compared with colloid goiter and GD
patients (P< .001 for both) (Fig. 1E, F, 2C). ZO-1 immunopo-
sitivity did not differ significantly between these 2 last groups of
patients (P= .47).
CD68-positive macrophages of both intra- and extrafollicular
localization were observed in all tissue samples. The cells were
irregularly shaped and displayed a vacuolated cytoplasmic
appearance being arranged either in clusters or individually
distributed within the thyroid follicles (Fig. 1G, H). Large clusters
of intrafollicular CD68-positive cells were found exclusively in
HT patients, whereas occasional CD68 positive cells – mostly in
GD and colloid goiter. Lymphocytes, along with macrophages,
were also seen within the follicles. A significantly higher number
of thyroid follicles with CD68-positive cells was found in HT
patients than that in patients with GD or colloid goiter (P= .05
and P= .001, respectively) (Fig. 2D). CD68 positivity observed in
GD patients was higher than colloid goiter, but the difference was
not significant (P= .06).
In HT patients, the expression of IL-17A in the follicular cells
was positively correlated with intrafollicular CD68 immunopo-
sitivity (r=0.631, P= .005). When analyzing the correlation
between IL-17A and Tj proteins expression, no significant
relationship between IL-17A and ZO-1 or claudin-1 was found in
HT patients (r=0.267, P= .28 and r=0.194, P= .44, respective-
ly). GD patients did not reveal any significant correlation of IL-
17A with Tj – ZO-1 and claudin-1 (r= -0.199, P= .67 and r=
0.734, P= .06, respectively) and CD68 (r=0.631, P= .13).
4. Discussion
Although Th1-driven autoimmune response has long been
considered as dominant for HT development, recent studies
are suggesting an evident participation of Th17 cells in AITD,
particularly HT pathogenesis. In our study, we identified higher
expression levels of tissue IL-17A assessed by immunohistochem-
istry in thyroid samples fromHT patients compared with GD and
colloid goiter. Similarly, Li et al[24] detected that HT patients
exhibited increased levels of thyroid tissue infiltrating Th17 cells
as well as higher IL-17 levels in sera than controls and patients
with other thyroid pathologies. In addition, an association
between thyroid IL-17 expression and fibrosis evidenced within
the gland stroma was demonstrated in patients suffering from
Figure 2. Comparison of immunohistochemical results between Hashimoto thyroiditis (n=18), Graves’ disease (n=7), and colloid goiter (n=10) patients. (A)
represents expression levels of IL-17A, (B) the number of CD68-positive thyroid follicles, (C) claudin-1 expression levels, and (D) immunopositivity levels of ZO-1 in
AITD and colloid goiter patients. Comparisons were made by Mann–Whitney U test. Data are shown as median (interquartile range); AITD=autoimmune thyroid
diseases, IL= interleukin, ZO=zonula occludens.
∗
P< .05.
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HT.[24] Figueroa-Vega et al[6] evidenced increased levels of IL-22
and IL-17 both in colonizing thyroid tissue and peripheral blood
from HT patients, as wells as high levels of Th17 differentiation
affecting cytokines, such as IL-6, IL-15, and IL-23. Finally, Konca
Degertekin et al[25] found that HT patients displaying normal
thyroid function had higher circulating levels of IL-17 and IL-23
than HT patients suffering from hypothyroidism suggesting that
hypothyroidism may have an inhibitory effect on cytokine
production. Overall, these findings provide strong supportive
evidence of Th17 cell involvement in the development of HT.
Participation of Th17 lymphocytes and their produced
cytokines in GD pathogenesis is less understood; however, Peng
et al[26] indicated significantly enhanced levels of both Th22 and
Th17 cells revealed in peripheral blood, paralleled by higher
detectable concentrations of IL-22 and IL-17 in blood plasma of
Chinese patients with newly diagnosed GD compared with
controls. We also found a difference in IL-17A expression
between GD and colloid goiter. Still, it seems the association
between Th17 lymphocytes and development of GD is less
obvious than that of HT.
IL-17A positive cells were found within inflammatory cell
infiltrates invading the thyroid gland. Apart from inflammatory
cells, the given study demonstrated a strongly marked
expression of IL-17 in the thyroid follicular cells surrounded
by lymphocytes or located close to them. Various cell types,
including epithelial, Paneth cells and smooth muscular cells,
neutrophils and mast cells, natural killer cells as well as Yd and
abT lymphocytes have been recognized to express IL-17 fromA
to F.[27] Previous studies have revealed that thyroid follicular
cells expressing MHC class II molecules colocalized with B7.1
antigens and interacting with CD4+ T cells allow the thyrocyte
to act as an antigen-presenting cell initiating and/ormaintaining
the autoimmune process.[28] Therefore, thyrocytes may have a
much larger role to play in the pathogenesis of AITD than
initially thought.
A vast majority of intrafollicular CD68-positive cells were
observed in patients with HT being indicative of their migration
to the thyroid follicular lumen. It is worth noting that these
patients displayed a strong positive correlation between CD68
and IL-17A immunopositivity as well. Although we have not
found any significant correlation between IL-17 and Tj proteins
expression, accumulation of macrophages in the follicular lumen
can be interpreted as an impairment of thyroid epithelium
integrity. It has been reported previously that anti-TPO anti-
bodies caused damage of cultured thyrocytes performed upon
binding to TPO located on the apical cell membrane via both
antibody (ADCC) and complement-dependent cytotoxicity;
moreover, the authors demonstrated that monocytes via their
FcgRI are pivotal players in ADCC mediated by thyroid
antibodies.[29] Thus, understanding and describing the role of
intrafollicular macrophages in HT pathogenesis is of great
interest.
Due to the structural peculiarities of the wall of thyroid
follicle, the pass for anti-TPO antibodies attempting to get
access to the molecule expressed on the apical pole of thyrocyte
facing colloid and nonaccessible to immune cells is still poorly
understood. Some studies have assumed that TPO might be
translocated by lateral diffusion to the basolateral pole of the
thyrocytes and recognized by macrophages and/or dendritic
cells.[30] Another explanation of the disturbance of follicular
integrity highlights modifications of Tj proteins enabling the
migration of antigen-presenting cells across thyroid follicular
epithelium.[31]
In this study, we evaluated Tj ZO-1 and claudin-1 protein
immunoreactivity in thyroid tissues obtained from patients
with AITD and colloid goiter. A significant reduction in ZO-1
expression noted in our study in HT patients correlates
with the disturbed integrity of thyroid epithelium that appears
in HT. By contrast, a higher number of claudin-1 positive
follicles in HT patients was demonstrated in HT when
compared with colloid goiter. The aforementioned differences
in claudin-1 and ZO-1 expression observed between HT and
GD patients are in agreement with a study describing under-
expression of ZO-1 in thyroid tissues of HT patients, although
claudin-1 appeared to be more strongly expressed.[31] We
speculate that increased claudin-1 immunoreactivity in HT
patients might be interpreted as a cell survival and/or
compensatory mechanism.
Several paracrine factors including cytokines and growth
factors have been recognized as ones affecting the distribution of
Tj and regulating the epithelial barrier function.[32] IL-17A was
shown to downregulate expression of occludin thus having a
disruptive effect on the hematoencephalic and testicular barri-
er.[21,22] However, whether the elevated IL-17 in HT affects Tj
integrity and thereby alters the barrier function of thyroid
follicular cells is unknown. A distinguishable negative effect of IL-
1a on Tj and a loss of epithelial cell integrity have been described
previously in cultured thyroid cells.[33] Recently, Rebuffat et al[31]
showed that Tj protein – ZO-1, claudin-1, and JAM-A protein
organization and expression as well as localization in the thyroid
tissue of patients suffering from AITD are modified by
proinflammatory cytokine IL-1b thus affecting thyroid epitheli-
um integrity. Zhang et al[34] explored the signaling pathway that
links IL-17 with Tj in salivary gland cell culture and postulated
that IL-17 could directly modulate Tj protein expression and
distribution through the NF-kB signaling pathway. To evaluate
whether there is a relationship between IL-17 and Tj disruption,
we did correlation analysis between the levels of IL-17 and Tj
proteins expression in AITD patients, but no significant
association with IL-17A was found.
We recognize limitations of our study, including a small
number of thyroid tissue sections, semiquantitative measures of
immunoexpression, and the lack of data regarding the
expression of Treg cytokines, as nowadays both T cell types
should be investigated as important players in AITD pathogen-
esis. The given study was retrospective in nature and thus was
based on analysis of archived paraffin-embedded tissues.
Because of methodological limitations, our knowledge about
cytokine-regulated Tj disruption remains insufficient and
interpretation of our findings regarding the association of IL-
17 and Tj should be cautious. Therefore, further prospective
studies based on larger number of samples and methods
estimating causal effect between IL-17 and Tj disruption are
required. A growing number of evidence including this
deciphering autoimmune disease demonstrates involvement
of Tj barrier disruption and increased paracellular permeabili-
ty.[35] Therefore, we believe that a proper understanding of the
pathogenic role of IL-17 and the imbalance in the expression
and distribution of Tj in AITD may contribute to the
development of new therapeutic approaches in the future.
5. Conclusion
Our study evidenced a strong IL-17A overexpression in the
thyroid epithelial cells associated with the presence of intra-
follicular CD68-positive cells in HT patients, suggesting that the
Zake et al. Medicine (2018) 97:25 www.md-journal.com
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role of affected thyrocytes and antigen-presenting cells in thyroid
autoimmunity might extend far deeper than initially thought.
Simultaneously, we evidenced the changes in molecules of
thyrocyte junctional complexes highlighting impairment of the
thyroid follicle integrity inHT, but no significant association with
IL-17A was found.
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